 | Join us on January 19, 2022 at 2:00pm ET Speed to market remains a key driver for the digitalization of long-standing paper-based processes in drug manufacturing. Bottlenecks such as manual execution and review—all associated with bloated documentation—prevent companies from aligning with the FDA’s vision for advanced manufacturing to achieve continuous improvement. Manufacturers like GlaxoSmithKline (GSK) are embracing Pharma 4.0 and paperless technologies to help bring quality medicines to patients more quickly. Join Pharma Manufacturing editors, Andrew Jenkins, IT Director from GSK, and Craig Resnick, VP of Consulting from ARC, as they discuss:
By clicking “Register Now” and submitting your information for this webinar, you are sharing your information with Aspen Technology, Inc (“AspenTech”). AspenTech is collecting and may process your personal data for a variety of reasons related to our respective business and ability to deliver the best possible products, customer support service and overall user experience. Accordingly, AspenTech may use your personal data to contact you regarding your interest in this webinar, send you related content, administer research surveys, to accurately deliver contracted services, to register you for events, to understand your preferences and to detect and prevent any fraudulent or unauthorized activities. Please refer to AspenTech’s Privacy Policy (https://www.aspentech.com/en/privacy-and-security) for more information regarding the collection and processing of your personal data, including your rights and ability to opt-out. Request Free! |
